Hypothesis

2 Matching Annotations

Aug 2026
pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov

Phase I trial of Ipatasertib plus Atezolizumab enhances PI3K/AKT pathway immune responses in solid tumors and refractory glioblastoma

1
1. scibot 05 Aug 2026
  
  in Public
  
  RRID:AB_836890
  
  DOI: 10.1158/1078-0432.CCR-25-4364
  
  Resource: (Cell Signaling Technology Cat# 4528, RRID:AB_836890)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_836890
  
  What is this?
  
  RRID:AB_836890
Visit annotations in context

Tags

RRID:AB_836890

Annotators

scibot

URL

pmc.ncbi.nlm.nih.gov/articles/PMC13430223/
Sep 2020
www.sciencedirect.com www.sciencedirect.com

Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic Cancer

1
1. scibot 09 Sep 2020
  
  in Public
  
  RRID:AB_836890
  
  DOI: 10.1016/j.ccell.2020.02.008
  
  Resource: (Cell Signaling Technology Cat# 4528, RRID:AB_836890)
  
  Curator: @ethanbadger
  
  SciCrunch record: RRID:AB_836890
  
  What is this?
  
  RRID:AB_836890 RRIDCUR:Validated
Visit annotations in context

Tags

RRIDCUR:Validated

RRID:AB_836890

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S1535610820300970